Methemoglobinemia Following Intravenous Iron Treatment
NCT06309641
Anemia, Hematologic Diseases
Falun, Sweden
View Trial DetailsNCT Number: NCT01766999
Tumescent local anesthesia is a procedure which is frequently performed for plastic cosmetic surgical procedures such as liposuction. The subcutaneous adipose tissue is infiltrated with large volumes of a solution which also contain local anesthetics. However local anesthetics, can also lead to a marked production of methemoglobin. New generation pulse oximeters are able to measure SpMetHb non-invasivly.
The aim of this study is:
1. to investigate multi-wavelength pulse oximetry as a monitoring method for patients at increased risk for methemoglobinemia. 2. to illustrate MetHb concentrations over a course of 24 hours after a liposuction employing tumescent anesthesia has been carried out.
Looking for future studies?
Notify Me18 year–99 year
Female
Observational
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 24 hours
Time frame: 24 hours
University Hospital Schleswig-Holstein
Other
Methemoglobinemia After Liposuction Under Tumescent Local Anesthesia - Timecourse and Diagnostics by Pulse Oximetry and Blood Gas Analysis.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06309641
Anemia, Hematologic Diseases
Falun, Sweden
View Trial DetailsNCT06958822
Anemia, Anemia, Hypochromic
Adana, Turkey (Türkiye)
View Trial DetailsNCT02478281
Congenital Methemoglobinemia, Hematologic Diseases
View Trial DetailsNCT03542760
Hematologic Diseases, Hemic and Lymphatic Diseases
Los Angeles, California, United States
View Trial Details